![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.297, 2001-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The cost of COPD in relation to disease severity in France
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 386, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adherence to COPD therapy lowers resource use, costs in US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 616, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Disease severity predicts costs in age-related macular degeneration
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 403, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Update on drug therapy for Alzheimer's disease
Inpharma, Vol. 1, Iss. 1338, 2002-01 ,pp. :